74 related articles for article (PubMed ID: 25738885)
21. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.
Wakefield A; Soukupova J; Montagne A; Ranger J; French R; Muller WJ; Clarkson RW
Cancer Res; 2013 Jan; 73(2):745-55. PubMed ID: 23149915
[TBL] [Abstract][Full Text] [Related]
22. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
24. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Notch1 in the development of mouse mammary tumors.
Diévart A; Beaulieu N; Jolicoeur P
Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
[TBL] [Abstract][Full Text] [Related]
26. Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.
Deng M; Jiang Z; Li Y; Zhou Y; Li J; Wang X; Yao Y; Wang W; Li P; Xu B
Oncotarget; 2016 Dec; 7(50):82200-82212. PubMed ID: 27203215
[TBL] [Abstract][Full Text] [Related]
27. SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation.
Gomez ML; Shah N; Kenny TC; Jenkins EC; Germain D
Oncogene; 2019 Jul; 38(29):5751-5765. PubMed ID: 31222103
[TBL] [Abstract][Full Text] [Related]
28. N-Oxide polymer-cupric ion nanogels potentiate disulfiram for cancer therapy.
Zhong Y; Sun R; Geng Y; Zhou Q; Piao Y; Xie T; Zhou R; Shen Y
Biomater Sci; 2020 Mar; 8(6):1726-1733. PubMed ID: 31995039
[TBL] [Abstract][Full Text] [Related]
29. In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
Costarelli L; Malavolta M; Giacconi R; Cipriano C; Gasparini N; Tesei S; Pierpaoli S; Orlando F; Suzuki H; Perbellini L; Piacenza F; Emanuelli M; Mocchegiani E
Oncol Res; 2010; 18(9):409-18. PubMed ID: 20524399
[TBL] [Abstract][Full Text] [Related]
30. The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Li Y; Zhang Y; Hill J; Shen Q; Kim HT; Xu X; Hilsenbeck SG; Bissonnette RP; Lamph WW; Brown PH
Clin Cancer Res; 2007 Oct; 13(20):6224-31. PubMed ID: 17947490
[TBL] [Abstract][Full Text] [Related]
31. Validation of an in vitro model of erbB2(+) cancer cell redirection.
Park JP; Blanding WM; Feltracco JA; Booth BW
In Vitro Cell Dev Biol Anim; 2015 Sep; 51(8):776-86. PubMed ID: 25898824
[TBL] [Abstract][Full Text] [Related]
32. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer.
Rossdeutscher L; Li J; Luco AL; Fadhil I; Ochietti B; Camirand A; Huang DC; Reinhardt TA; Muller W; Kremer R
Cancer Prev Res (Phila); 2015 Feb; 8(2):120-8. PubMed ID: 25468832
[TBL] [Abstract][Full Text] [Related]
34. Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145.
Mallet JF; Shahbazi R; Alsadi N; Saleem A; Sobiesiak A; Arnason JT; Matar C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835085
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.
Marcotte R; Muller WJ
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209
[TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes on promoting the growth of breast cancer.
Chou PC; Choi HH; Huang Y; Fuentes-Mattei E; Velazquez-Torres G; Zhang F; Phan L; Lee J; Shi Y; Bankson JA; Wu Y; Wang H; Zhao R; Yeung SJ; Lee MH
Cancer Commun (Lond); 2021 May; 41(5):414-431. PubMed ID: 33609419
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.
Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H
Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719
[TBL] [Abstract][Full Text] [Related]
38. Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.
Louzada S; Adega F; Chaves R
PLoS One; 2012; 7(1):e29923. PubMed ID: 22253826
[TBL] [Abstract][Full Text] [Related]
39. In vivo selection for metastasis promoting genes in the mouse.
Gumireddy K; Sun F; Klein-Szanto AJ; Gibbins JM; Gimotty PA; Saunders AJ; Schultz PG; Huang Q
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6696-701. PubMed ID: 17420453
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing factor reduces tumor volume, halts further growth, and enhances the effect of chemotherapy in 4T1 mammary carcinoma in mice.
Stuhr LE; Wei ET; Reed RK
Tumour Biol; 2014 Feb; 35(2):1365-70. PubMed ID: 24046091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
